Skip to main content
PMC home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1963 Feb;20(1):36–55. doi: 10.1111/j.1476-5381.1963.tb01295.x

Adrenergic neurone blockade and other acute effects caused by n-benzyl-n'n”-dimethylguanidine and its ortho-chloro derivative*

A L A Boura, A F Green
PMCID: PMC1703738  PMID: 14014418

Abstract

N-Benzyl-N'N”-dimethylguanidine sulphate (BW 467C60) and its ortho-chloro derivative (BW 392C60) had adrenergic neurone blocking and sympathomimetic effects resembling those of bretylium and guanethidine in cats, dogs and monkeys, but they were more potent in blocking adrenergic mechanisms in the cat. BW 467C60 was more active than its chloro derivative. Each compound inhibited release of noradrenaline during stimulation of the splenic nerve of cats, and increased smooth muscle responses to adrenaline and noradrenaline. Pressor responses to standard doses of tyramine were also increased except when large doses of BW 467C60 or BW 392C60 were given. The adrenergic neurone block by BW 467C60 was inhibited by dopamine, cocaine and amphetamine in situations in which these amines inhibit the effects of bretylium and guanethidine. In contrast to guanethidine, BW 467C60 and BW 392C60 did not lower the pressor amine content of the iris of cats 24 hr after administration of single doses of the compounds. BW 467C60 depressed the slope of curves relating the frequency of stimuli applied to the cervical sympathetic nerves and the resulting contraction of the nictitating membrane, but the effects of the lower rates of stimulation were preferentially inhibited. Large intravenous doses of BW 467C60 and BW 392C60 blocked autonomic cholinergic mechanisms and caused neuromuscular paralysis of voluntary muscle. These effects were brief, in contrast to the adrenergic neurone blockade. Both BW 467C60 and BW 392C60 were well absorbed from the alimentary tract. In contrast to guanethidine, BW 467C60 did not cause diarrhoea in guinea-pigs.

Full text

PDF
52

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARTLET A. L. The pressor action of guanethidine in the spinal cat. J Pharm Pharmacol. 1962 Feb;14:91–95. doi: 10.1111/j.2042-7158.1962.tb11058.x. [DOI] [PubMed] [Google Scholar]
  2. BOURA A. L., COPP F. C., DUNCOMBE W. G., GREEN A. F., McCOUBREY A. The selective accumulation of bretylium in sympathetic ganglia and their postganglionic nerves. Br J Pharmacol Chemother. 1960 Jun;15:265–270. doi: 10.1111/j.1476-5381.1960.tb01242.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BOURA A. L., COPP F. C., GREEN A. F., HODSON H. F., RUFFELL G. K., SIM M. F., WALTON E., GRIVSKY E. M. Adrenergic neurone-blocking agents related to choline 2, 6-xylyl ether bromide (TM 10), bretylium and guanethidine. Nature. 1961 Sep 23;191:1312–1313. doi: 10.1038/1911312a0. [DOI] [PubMed] [Google Scholar]
  4. BOURA A. L., DUNCOMBE W. G., ROBSON R. D., McCOURBREY A. The distribution and excretion by cats of a new hypotensive drug, N-benzyl-N'N"-dimethylguanidine. J Pharm Pharmacol. 1962 Nov;14:722–726. doi: 10.1111/j.2042-7158.1962.tb11166.x. [DOI] [PubMed] [Google Scholar]
  5. BOURA A. L., GREEN A. F. Comparison of bretylium and guanethidine: tolerance, and effects on adrenergic nerve function and responses to sympathomimetic amines. Br J Pharmacol Chemother. 1962 Aug;19:13–41. doi: 10.1111/j.1476-5381.1962.tb01424.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. BOURA A. L., GREEN A. F. The actions of bretylium: adrenergic neurone blocking and other effects. Br J Pharmacol Chemother. 1959 Dec;14:536–548. doi: 10.1111/j.1476-5381.1959.tb00961.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. BROWN G. L., GILLESPIE J. S. The output of sympathetic transmitter from the spleen of the cat. J Physiol. 1957 Aug 29;138(1):81–102. doi: 10.1113/jphysiol.1957.sp005839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. CASS R., KUNTZMAN R., BRODIE B. B. Norepinephrine depletion as a possible mechanism of action of guanethidine (SU 5864), a new hypotensive agent. Proc Soc Exp Biol Med. 1960 Apr;103:871–872. doi: 10.3181/00379727-103-25702. [DOI] [PubMed] [Google Scholar]
  9. CASS R., SPRIGGS T. L. Tissue amine levels and sympathetic blockade after guanethidine and bretylium. Br J Pharmacol Chemother. 1961 Dec;17:442–450. doi: 10.1111/j.1476-5381.1961.tb01131.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. COSTA E., KUNTZMAN R., GESSA G. L., BRODIE B. B. Structural requirements for bretylium and guanethidine-like activity. Life Sci. 1962 Mar;1:75–80. doi: 10.1016/0024-3205(62)90032-2. [DOI] [PubMed] [Google Scholar]
  11. DAY M. D. Effect of sympathomimetic amines on the blocking action of guanethidine, bretylium and xylocholine. Br J Pharmacol Chemother. 1962 Apr;18:421–439. doi: 10.1111/j.1476-5381.1962.tb01421.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. DENGLER H. J., SPIEGEL H. E., TITUS E. O. Effects of drugs on uptake of isotopic norepinephrine by cat tissues. Nature. 1961 Aug 19;191:816–817. doi: 10.1038/191816a0. [DOI] [PubMed] [Google Scholar]
  13. Finkleman B. On the nature of inhibition in the intestine. J Physiol. 1930 Sep 18;70(2):145–157. doi: 10.1113/jphysiol.1930.sp002683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. GREEN A. F. Comparative effects of analgesics on pain threshold, respiratory frequency and gastrointestinal propulsion. Br J Pharmacol Chemother. 1959 Mar;14(1):26–34. doi: 10.1111/j.1476-5381.1959.tb00924.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gaddum J. H., Peart W. S., Vogt M. The estimation of adrenaline and allied substances in blood. J Physiol. 1949 Jun 15;108(4):467–481. doi: 10.1113/jphysiol.1949.sp004350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. HERTTING G., AXELROD J., PATRICK R. W. Actions of bretylium and guanethidine on the uptake and release of [3H]-noradrenaline. Br J Pharmacol Chemother. 1962 Feb;18:161–166. doi: 10.1111/j.1476-5381.1962.tb01159.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. KADZIELAWA K. Mechanism of action of guanethidine. Br J Pharmacol Chemother. 1962 Aug;19:74–84. doi: 10.1111/j.1476-5381.1962.tb01428.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. KUNTZMAN R., COSTA E., GESSA G. L., BRODIE B. B. Reserpine and guanethidine action on peripheral stores of catecholamines. Life Sci. 1962 Mar;1:65–74. doi: 10.1016/0024-3205(62)90031-0. [DOI] [PubMed] [Google Scholar]
  19. LINDGREN P. An improved method for drop recording of arterial or venous blood flow. Acta Physiol Scand. 1958 Feb 10;42(1):5–11. doi: 10.1111/j.1748-1716.1958.tb01536.x. [DOI] [PubMed] [Google Scholar]
  20. MAXWELL R. A., PLUMMER A. J., SCHNEIDER F., POVALSKI H., DANIEL A. I. Pharmacology of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (Su-5864). J Pharmacol Exp Ther. 1960 Jan;128:22–29. [PubMed] [Google Scholar]
  21. PONTEN B. Quantative measurements of sweat gland activity using the ninhydrin method. Acta Physiol Scand. 1960 Jan 30;48:20–28. doi: 10.1111/j.1748-1716.1960.tb01842.x. [DOI] [PubMed] [Google Scholar]
  22. von EULER U., LISHAJKO F. Effect of reserpine on the release of catecholamines from isolated nerve and chromaffin cell granules. Acta Physiol Scand. 1961 Jun;52:137–145. doi: 10.1111/j.1748-1716.1961.tb02209.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES